Every SEC Form 3/4/5 on record for this filer (CIK 1612551) — 8 issuers, 68 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | Director | 2024-10-23 → 2026-06-30 | 7 | $500,050 |
| ZURA | Zura Bio Ltd | Director | 2023-03-21 → 2026-06-22 | 8 | $999,998 |
| ARQT | Arcutis Biotherapeutics, Inc. | Director | 2025-12-08 → 2026-06-09 | 3 | — |
| GLTO | Galecto, Inc. | Director | 2020-10-28 → 2025-06-20 | 6 | — |
| ARNA | ARENA PHARMACEUTICALS INC | President and CEO · Director · lapsed | 2016-05-11 → 2022-03-11 | 25 | −$29M |
| DNAD | Social Capital Suvretta Holdings Corp. IV | Director · lapsed | 2021-06-29 → 2021-06-29 | 1 | — |
| PULM | Pulmatrix, Inc. | Director · lapsed | 2017-06-15 → 2021-02-01 | 7 | — |
| EPRS | EPIRUS Biopharmaceuticals, Inc. | Chief Executive Officer · Director · lapsed | 2015-07-06 → 2016-03-01 | 8 | $221,797 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| IKT | 2024-10-21 | Buy | 365,000 | $1.37 | $500,050 | 365,000 |
| ZURA | 2024-04-22 | Buy | 159,744 | $3.13 | $499,999 | 777,384 |
| ZURA | 2023-06-05 | Buy | 117,647 | $4.25 | $500,000 | 617,640 |
4 of 8 issuers are covered and open a security page; the rest are on file here only.
